926 related articles for article (PubMed ID: 28035069)
1. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
[TBL] [Abstract][Full Text] [Related]
2. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
Tao Y; Han T; Zhang T; Ma C; Sun C
Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
[TBL] [Abstract][Full Text] [Related]
3. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
Zhang H; Sun JD; Yan LJ; Zhao XP
Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
[TBL] [Abstract][Full Text] [Related]
4. microRNA-335 inhibits colorectal cancer HCT116 cells growth and epithelial-mesenchymal transition (EMT) process by targeting Twist1.
Wang J; Wang X; Liu F; Fu Y
Pharmazie; 2017 Aug; 72(8):475-481. PubMed ID: 29441907
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
6. The long noncoding RNA TUG1 is required for TGF-β/TWIST1/EMT-mediated metastasis in colorectal cancer cells.
Shen X; Hu X; Mao J; Wu Y; Liu H; Shen J; Yu J; Chen W
Cell Death Dis; 2020 Jan; 11(1):65. PubMed ID: 31988275
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
8. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways.
Ahmad A; Wang Z; Kong D; Ali R; Ali S; Banerjee S; Sarkar FH
Breast Cancer Res Treat; 2011 Feb; 126(1):15-25. PubMed ID: 20379844
[TBL] [Abstract][Full Text] [Related]
10. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
11. Quercetin restrains TGF-β1-induced epithelial-mesenchymal transition by inhibiting Twist1 and regulating E-cadherin expression.
Feng J; Song D; Jiang S; Yang X; Ding T; Zhang H; Luo J; Liao J; Yin Q
Biochem Biophys Res Commun; 2018 Mar; 498(1):132-138. PubMed ID: 29425820
[TBL] [Abstract][Full Text] [Related]
12. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J
Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.
Wang Z; Kong D; Banerjee S; Li Y; Adsay NV; Abbruzzese J; Sarkar FH
Cancer Res; 2007 Dec; 67(23):11377-85. PubMed ID: 18056465
[TBL] [Abstract][Full Text] [Related]
14. Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer.
Fan LC; Teng HW; Shiau CW; Tai WT; Hung MH; Yang SH; Jiang JK; Chen KF
Oncotarget; 2016 Sep; 7(39):64136-64147. PubMed ID: 27580057
[TBL] [Abstract][Full Text] [Related]
15. Twist1 regulates the epithelial-mesenchymal transition via the NF-κB pathway in papillary thyroid carcinoma.
Lv N; Shan Z; Gao Y; Guan H; Fan C; Wang H; Teng W
Endocrine; 2016 Mar; 51(3):469-77. PubMed ID: 26289126
[TBL] [Abstract][Full Text] [Related]
16. Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis.
Yusup A; Huji B; Fang C; Wang F; Dadihan T; Wang HJ; Upur H
World J Gastroenterol; 2017 Jan; 23(1):110-120. PubMed ID: 28104986
[TBL] [Abstract][Full Text] [Related]
17. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.
Kim YH; Kim G; Kwon CI; Kim JW; Park PW; Hahm KB
Oncol Rep; 2014 Mar; 31(3):1380-8. PubMed ID: 24402192
[TBL] [Abstract][Full Text] [Related]
18. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.
Wang L; Lin L; Chen X; Sun L; Liao Y; Huang N; Liao W
Oncotarget; 2015 May; 6(13):11492-506. PubMed ID: 25895023
[TBL] [Abstract][Full Text] [Related]
19. Influence of the Twist gene on the invasion and metastasis of colon cancer.
Wang D; Rai B; Qi F; Liu T; Wang J; Wang X; Ma B
Oncol Rep; 2018 Jan; 39(1):31-44. PubMed ID: 29115546
[TBL] [Abstract][Full Text] [Related]
20. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
